YubinKangMD

PubMed

• Longitudinal intravital imaging of mouse placenta.
  Xiaoyi Zhu, Qiang Huang, Laiming Jiang, Van-Tu Nguyen, Tri Vu, Garth Devlin, Jabbar Shaima, Xiaobei Wang, Yong Chen, Lijun Ma, Kun Xiang, Ergang Wang, Qiangzhou Rong, ...> ;Science Advances. 2024 Mar 22
• Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.
  Kun Xiang, Ergang Wang, John Mantyh, Gabrielle Rupprecht, Marcos Negrete, Golshid Sanati, Carolyn Hsu, Peggy Randon, Anders Dohlman, Kai Kretzschmar, Shree Bose, Nicho...> ;Advanced Science. 2024 Feb 21
• Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Kumar, S., Callander, N., Adekola, K., Anderson, L., Baljevic, M., Baz, R., Campagnaro, E., Castillo, J., Costello, C., D'Angelo, C., Derman, B., Devarakonda, S., Else...> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 1
• 1 citations
  Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christoph...> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 1
• SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments.
  Emily Chu, Jian Wu, Stacey S Kang, Yubin Kang> ;Current Oncology. 2023 Aug 27
• 2 citations
  RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect.
  Jian Wu, Xiaobei Wang, Min Zhang, Yubin Kang, Mathews, P., Parker Mathews> ;Cells. 2023 Aug 3
• Coinciding kappa AL amyloidosis and kappa light chain deposition disease in the lung.
  Derald D Charles, Elizabeth N Pavlisko, Jadee L Neff, Yubin Kang, John M Carney> ;Virchows Archiv. 2023 Nov 1
• 2 citations
  Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma.
  Jian Wu, Shengjun Fan, Daniel Feinberg, Xiaobei Wang, Shaima Jabbar, Yubin Kang> ;Current Oncology. 2023 Mar 4
• 7 citations
  A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
  Chenyu Lin, Rachel A DiCioccio, Tarek Haykal, William C McManigle, Zhiguo Li, Sarah M Anand, Jonathan C Poe, Sonali J Bracken, Wei Jia, Edwin P Alyea 3rd, Adela R Card...> ;Transplantation and Cellular Therapy. 2023 Mar 1
• 5 citations
  Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christopher D'Angelo,...> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• 6 citations
  Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
  Yubin Kang, Pasupathi Sundaramoorthy, Cristina Gasparetto, Daniel Feinberg, Shengjun Fan, Gwynn Long, Emily Sellars, Anderson Garrett, Sascha A Tuchman, Brandi N Reeve...> ;Annals of Hematology. 2023 Feb 1
• 2 citations
  Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor.
  Shaima Jabbar, Parker Mathews, Xiaobei Wang, Pasupathi Sundaramoorthy, Emily Chu, Sadhna O Piryani, Shengli Ding, Xiling Shen, Phuong L Doan, Yubin Kang> ;Experimental Hematology & Oncology. 2022 Oct 31
• 2 citations
  Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma.
  Jian Wu, Emily Chu, Barry Paul, Yubin Kang> ;Cancers. 2022 Oct 27
• 5 citations
  PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo.
  Yonggang Sha, Jian Wu, Barry Paul, Yue Zhao, Parker Mathews, Zhiguo Li, John Norris, Endi Wang, Donald P McDonnell, Yubin Kang> ;Cancer Letters. 2022 Oct 1
• 3 citations
  Emerging Evidence of the Significance of Thioredoxin-1 in Hematopoietic Stem Cell Aging.
  Shaima Jabbar, Yubin Kang, Mathews, P., Parker Mathews> ;Antioxidants. 2022 Jun 29
• 2 citations
  Anaplastic Multiple Myeloma: Case Series and Literature Review.
  Jian Wu, Emily Chu, Cristiana Costa Chase, Taewoong Choi, Cristina Gasparetto, Ken Young, Yubin Kang> ;Asploro Journal of Biomedical and Clinical Case Reports. 2022 Jan 15
• 70 citations
  NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
  Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, Larry D Anderson, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Srinivas Devarakonda, Noura Elsedawy, M...> ;Journal of the National Comprehensive Cancer Network. 2022 Jan 1
• 225 citations
  Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I Carlo, Toni K Choueiri, Brian A Costello, Ithaar H Derweesh, Arpi...> ;Journal of the National Comprehensive Cancer Network. 2022 Jan 1
• 3 citations
  An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report.
  Yubin Kang, Andrew J Armstrong, David S Hsu> ;Stem Cell Investigation. 2022 Jan 1
• 18 citations
  Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies.
  Susan Bal, Ehsan Malek, Ankit Kansagra, Saad Z. Usmani, Ravi Vij, Kelly N. Godby, Yubin Kang, Elvira Umyarova, Smith Giri, Saurabh Chhabra, Michaela Liedtke, Natalie S...> ;Leukemia. 2021 Nov 20
• 10 citations
  Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma.
  Taewoong Choi, Yubin Kang> ;Pharmacology & Therapeutics. 2021 Sep 25
• 11 citations
  PIM Kinases in Multiple Myeloma
  Jian Wu, Emily Chu, Yubin Kang> ;Cancers. 2021 Aug 26
• 13 citations
  Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
  Wei Huang, Yaping Liu, Anthony L. Luz, Mark Berrong, Joel N. Meyer, Yujing Zou, Excel Swann, Pasupathi Sundaramoorthy, Yubin Kang, Shekeab Jauhari, William Lento, Nels...> ;Frontiers in Immunology. 2021 Oct 12
• 20 citations
  Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;American Journal of Hematology. 2021 Jan 1
• 14 citations
  Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
  Ko K. Maung, Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, Gwynn D. Long, Ashley Morris Engemann, Barbara Waters-Pick...> ;Bone Marrow Transplantation. 2021 Jan 1
• Join now to see all

Abstracts/Posters

• Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
  Yubin Kang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
  Yubin Kang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018